Our country is facing a national health care crisis due to ongoing and worsening shortages of essential, lifesaving generic drugs—a crisis that has been exacerbated by decades of offshoring our nation’s generic drug manufacturing capacity and a growing dependence on foreign manufacturers and supply chains.

The PILLS Act is bipartisan legislation to incentivize the strategic reshoring of U.S. domestic production of generic medicines.